Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-phenylspiro[1,3-dihydro-1,4-diazepine-2,3'-quinuclidine] is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1350363-81-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1350363-81-3 Structure
  • Basic information

    1. Product Name: 6-phenylspiro[1,3-dihydro-1,4-diazepine-2,3'-quinuclidine]
    2. Synonyms: 6-phenylspiro[1,3-dihydro-1,4-diazepine-2,3'-quinuclidine]
    3. CAS NO:1350363-81-3
    4. Molecular Formula:
    5. Molecular Weight: 267.374
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1350363-81-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 6-phenylspiro[1,3-dihydro-1,4-diazepine-2,3'-quinuclidine](CAS DataBase Reference)
    10. NIST Chemistry Reference: 6-phenylspiro[1,3-dihydro-1,4-diazepine-2,3'-quinuclidine](1350363-81-3)
    11. EPA Substance Registry System: 6-phenylspiro[1,3-dihydro-1,4-diazepine-2,3'-quinuclidine](1350363-81-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1350363-81-3(Hazardous Substances Data)

1350363-81-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1350363-81-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,0,3,6 and 3 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1350363-81:
(9*1)+(8*3)+(7*5)+(6*0)+(5*3)+(4*6)+(3*3)+(2*8)+(1*1)=133
133 % 10 = 3
So 1350363-81-3 is a valid CAS Registry Number.

1350363-81-3Downstream Products

1350363-81-3Relevant articles and documents

Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): Application to the design of related α7 selective ligands

Kombo, David C.,Mazurov, Anatoly,Tallapragada, Kartik,Hammond, Philip S.,Chewning, Joseph,Hauser, Terry A.,Vasquez-Valdivieso, Montserrat,Yohannes, Daniel,Talley, Todd T.,Taylor, Palmer,Caldwell, William S.

, p. 5625 - 5635 (2011)

AChBPs isolated from Lymnaea stagnalis (Ls), Aplysia californica (Ac) and Bulinus truncatus (Bt) have been extensively used as structural prototypes to understand the molecular mechanisms that underlie ligand-interactions with nAChRs [1]. Here, we describe docking studies on interactions of benzylidene anabaseine analogs with AChBPs and α7 nAChR. Results reveal that docking of these compounds using Glide software accurately reproduces experimentally-observed binding modes of DMXBA and of its active metabolite, in the binding pocket of Ac. In addition to the well-known nicotinic pharmacophore (positive charge, hydrogen-bond acceptor, and hydrophobic aromatic groups), a hydrogen-bond donor feature contributes to binding of these compounds to Ac, Bt, and the α7 nAChR. This is consistent with benzylidene anabaseine analogs with OH and NH2 functional groups showing the highest binding affinity of these congeners, and the position of the ligand shown in previous X-ray crystallographic studies of ligand-Ac complexes. In the predicted ligand-Ls complex, by contrast, the ligand OH group acts as hydrogen-bond acceptor. We have applied our structural findings to optimizing the design of novel spirodiazepine and spiroimidazoline quinuclidine series. Binding and functional studies revealed that these hydrogen-bond donor containing compounds exhibit improved affinity and selectivity for the α7 nAChR subtype and demonstrate partial agonism. The gain in affinity is also due to conformational restriction, tighter hydrophobic enclosures, and stronger cation-π interactions. The use of AChBPs structure as a surrogate to predict binding affinity to α7 nAChR has also been investigated. On the whole, we found that molecular docking into Ls binding site generally scores better than when a α7 homology model, Bt or Ac crystal structure is used.

Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs

Kombo, David C.,Mazurov, Anatoly A.,Chewning, Joseph,Hammond, Philip S.,Tallapragada, Kartik,Hauser, Terry A.,Speake, Jason,Yohannes, Daniel,Caldwell, William S.

experimental part, p. 1179 - 1186 (2012/03/26)

Based on pharmacophore elucidation and docking studies on interactions of benzylidene anabaseine analogs with AChBPs and α7 nAChR, novel spirodiazepine and spiroimidazoline quinuclidine series have been designed. Binding studies revealed that some of hydr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1350363-81-3